FDA Says Supplement AERs Will Be Subject To Lower Threshold Before Action
This article was originally published in The Tan Sheet
Executive Summary
FDA will continue to take actions against dietary supplement products prompted by a lower tolerance for adverse events than for other types of products, a policy reflected in its request for a recall the Hydroxycut weight-loss product line